Combination therapy with aromatase inhibitors: the next era of breast cancer treatment?
Open Access
- 22 August 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 95 (6), 661-666
- https://doi.org/10.1038/sj.bjc.6603316
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapyBreast Cancer Research and Treatment, 2007
- Fulvestrant in Women With Advanced Breast Cancer After Progression on Prior Aromatase Inhibitor Therapy: North Central Cancer Treatment Group Trial N0032Journal of Clinical Oncology, 2006
- The anti-oestrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF-7 breast cancer cells refractory to long-term oestrogen deprivation through down-regulation of oestrogen receptor and IGF signallingEndocrine-Related Cancer, 2005
- Tumor-Specific Expression of Vascular Endothelial Growth Factor Receptor 2 but Not Vascular Endothelial Growth Factor or Human Epidermal Growth Factor Receptor 2 Is Associated With Impaired Response to Adjuvant Tamoxifen in Premenopausal Breast CancerJournal of Clinical Oncology, 2005
- Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivityEndocrine-Related Cancer, 2005
- A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancerBreast Cancer Research and Treatment, 2005
- Molecular Classification of Tamoxifen-Resistant Breast Carcinomas by Gene Expression ProfilingJournal of Clinical Oncology, 2005
- Enhanced Estrogen Receptor (ER) α, ERBB2, and MAPK Signal Transduction Pathways Operate during the Adaptation of MCF-7 Cells to Long Term Estrogen DeprivationJournal of Biological Chemistry, 2003
- Phase II Study of the Efficacy and Tolerability of Two Dosing Regimens of the Farnesyl Transferase Inhibitor, R115777, in Advanced Breast CancerJournal of Clinical Oncology, 2003
- Phosphorylation of human estrogen receptor α at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antiseraOncogene, 2002